Sea Crest Wealth Management, LLC Axsome Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$13.46 - $25.75 $6,730 - $12,875	-500 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$2.63 - $16.34 $3,945 - $24,510	-1,500 Reduced 75.0%	500 $7,000
Q3 2018 Nov 14, 2018	BUY	$2.3 - $3.55 $4,600 - $7,100	2,000 New	2,000 $7,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.